Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Monday
October 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
MONDAY, OCTOBER 02, 2023
Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study

Coronavirus chronicle

Reuters
07 December, 2021, 10:35 am
Last modified: 07 December, 2021, 10:44 am

Related News

  • Djokovic withdraws from Indian Wells amid US visa row
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose
  • AstraZeneca's Covid vaccine suffers a setback in nasal spray trial
  • US foresees annual Covid boosters, just like flu: Officials

Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study

Reuters
07 December, 2021, 10:35 am
Last modified: 07 December, 2021, 10:44 am
Vials of coronavirus disease (Covid-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo
Vials of coronavirus disease (Covid-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo

A major British study into mixing Covid-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.

"We found a really good immune response across the board..., in fact, higher than the threshold set by Oxford-AstraZeneca vaccine two doses," Matthew Snape, the Oxford professor behind the trial dubbed Com-COV2, told Reuters.

The findings supporting flexible dosing will offer some hope to poor and middle income countries that may need to combine different brands between first and second shots if supplies run low or become unstable.

"I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they're still rolling out the first two doses of vaccines," Snape said.

"We're showing...you don't have to stick rigidly to receiving the same vaccine for a second dose...and that if the programme will be delivered more quickly by using multiple vaccines, then it is okay to do so."

If the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca-Oxford, according to researchers at the University of Oxford.

The study of 1,070 volunteers also found that a dose of the Pfizer-BioNTech , vaccine followed by a Moderna shot was better than two doses of the standard Pfizer-BioNTech course.

Pfizer-BioNTech followed by Novavax induced higher antibodies than the two-dose Oxford-AstraZeneca schedule, although this schedule induced lower antibody and T-cell responses than the two-dose Pfizer-BioNTech schedule.

No safety concerns were raised, according to the Oxford University study published in the Lancet medical journal.

Many countries have been deploying a mix and match well before robust data was available as nations were faced with soaring infection numbers, low supplies and slow immunisation over some safety concerns.

Longevity of protection offered by vaccines has been under scrutiny, with booster doses being considered as well amid surging cases. New variants, including Delta and Omicron, have now increased the pressure to speed up vaccination campaigns.

Blood samples from participants were tested against the Wild-Type, Beta and Delta variants, researchers of the Com-COV2 study said, adding that vaccines' efficacy against the variants had waned, but this was consistent across mixed courses.

Deploying vaccines using technology from different platforms - like Pfizer and Moderna's mRNA, AstraZeneca's viral vector and Novavax's protein-based shot - and within the same schedule is new.

The results may inform new approaches to immunisation against other diseases, he said.

The study also found that a first dose of the AstraZeneca-Oxford vaccine followed by any of the other candidates in the study generated a particularly robust response, consistent with findings in June.

The study was designed as a so-called "non-inferiority" study – the intent is to demonstrate that mixing is not substantially worse than the standard schedules - and compares the immune system responses to the gold-standard responses reported in previous clinical trials of each vaccine.

Top News

COVID vaccines / Covid-19 vaccines / Covid -19 vaccine / Pfizer coronavirus vaccine / Pfizer COVID vaccine / Pfizer Covid-19 Vaccine / Pfizer-19 Vaccine / AstraZeneca / AstraZeneca vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • DMP Commissioner Habibur Rahman at a press briefing on 2 October 2023. Photo: TBS
    If political parties gather without permission, strict action will be taken: DMP commissioner
  • Illustration: TBS
    Why do Bangladeshi universities fare so poorly in global rankings?
  • Solar panels at a field in a rural area of Bangladesh. File Photo: Rehman Asad/TBS
    Solar soon to be the most affordable electricity source for Bangladesh: Bloomberg

MOST VIEWED

  • Paperfly aborts flight
    Paperfly aborts flight
  • Photo: TBS
    Habibur Rahman takes charge as 36th DMP commissioner
  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Remittance earnings in September lowest in 41 months
  • How China's Belt and Road changing Bangladesh's  infrastructures
    How China's Belt and Road changing Bangladesh's infrastructures
  • Some banks get more remittance. Is it for extra efforts, or higher dollar rates?
    Some banks get more remittance. Is it for extra efforts, or higher dollar rates?
  • Representational image. Photo: Masum Billah
    Exporting mango trees to Dubai: Bangladeshi farmers tap into afforestation programmes in Gulf countries

Related News

  • Djokovic withdraws from Indian Wells amid US visa row
  • European regulator recommends Pfizer's Omicron booster for children
  • Pfizer expects to hike US Covid vaccine price to $110-$130 per dose
  • AstraZeneca's Covid vaccine suffers a setback in nasal spray trial
  • US foresees annual Covid boosters, just like flu: Officials

Features

Photo: Collected

Where did hamburgers come from?

8m | Food
Shahjahan Bhuiyan’s parents and two out of his three siblings passed away when he was behind bars. He missed all the funerals.  
Photo: Nayem Ali

Hangman Shahjahan Bhuiyan: Life after 60 executions and 44 years in prison

5h | Panorama
Illustration: Collected

Apology to a life forgotten to live

19h | Features
Photo: Kazi Ashraf Uddin

Coffee: More than a beverage, something of a beloved

22h | Features

More Videos from TBS

How much time do you spend on mobile apps?

How much time do you spend on mobile apps?

2h | Tech Talk
Everything about the ICC Cricket World Cup 2023 stadiums: Part 1

Everything about the ICC Cricket World Cup 2023 stadiums: Part 1

16h | TBS SPORTS
Apple is bringing new software updates to prevent overheating

Apple is bringing new software updates to prevent overheating

18h | Tech Talk
A unique study cafe in the city

A unique study cafe in the city

17h | TBS Stories
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]